NSAIDs and psoriasis

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, are often recommended as first-line treatments to ease pain, stiffness, and joint inflammation in mild psoriatic arthritis (PsA). While these medicines can provide effective short-term relief, they do not prevent progression or long-term joint damage. Some recent discussions have raised concerns that NSAIDs could trigger psoriasis or worsen existing skin symptoms, but the evidence remains limited and mixed.

Studies suggest that NSAIDs are unlikely to initiate psoriasis or PsA in otherwise healthy people, and there is little data to support a clear cause-and-effect relationship. In those who already have psoriasis or PsA, NSAIDs may exacerbate skin lesions in a small number of susceptible individuals, possibly through inflammatory pathways involving leukotrienes. However, most research indicates this risk is small compared with the benefits in symptom control.

The more significant safety concern with these medicines relates to gastrointestinal side effects, such as stomach ulceration or bleeding. For this reason, patients are often advised to take a proton pump inhibitor (PPI) alongside NSAIDs to protect the gut. Clinical guidelines continue to endorse NSAIDs as a reasonable option for managing PsA pain.

Further reading